These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 28435878)

  • 21. Fitness effects of CRISPR endonucleases in
    Langmüller AM; Champer J; Lapinska S; Xie L; Metzloff M; Champer SE; Liu J; Xu Y; Du J; Clark AG; Messer PW
    Elife; 2022 Sep; 11():. PubMed ID: 36135925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically Engineering the Nervous System with CRISPR-Cas.
    Sandoval A; Elahi H; Ploski JE
    eNeuro; 2020; 7(2):. PubMed ID: 32098761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic and diagnostic relevance of Crispr technology.
    El Ouar I; Djekoun A
    Biomed Pharmacother; 2021 Jun; 138():111487. PubMed ID: 33774312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
    Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
    Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
    Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
    [No Abstract]   [Full Text] [Related]  

  • 28. CRISPR/Cas-mediated editing of cis-regulatory elements for crop improvement.
    Saeed S; Usman B; Shim SH; Khan SU; Nizamuddin S; Saeed S; Shoaib Y; Jeon JS; Jung KH
    Plant Sci; 2022 Nov; 324():111435. PubMed ID: 36031021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel CRISPR-Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives.
    Nidhi S; Anand U; Oleksak P; Tripathi P; Lal JA; Thomas G; Kuca K; Tripathi V
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Exclusive Interview With CRISPR.
    McConnell SC
    AMA J Ethics; 2019 Dec; 21(12):E1079-1088. PubMed ID: 31876473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance analysis of novel toxin-antidote CRISPR gene drive systems.
    Champer J; Kim IK; Champer SE; Clark AG; Messer PW
    BMC Biol; 2020 Mar; 18(1):27. PubMed ID: 32164660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CRISPR/Cas systems in genome engineering of bacteriophages].
    Liang CJ; Meng FM; Ai YC
    Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repurposing prokaryotic clustered regularly interspaced short palindromic repeats-Cas adaptive immune system to combat antimicrobial resistance.
    Devi V; Harjai K; Chhibber S
    Future Microbiol; 2023 May; 18():443-459. PubMed ID: 37317864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.
    Shojaei Baghini S; Gardanova ZR; Abadi SAH; Zaman BA; İlhan A; Shomali N; Adili A; Moghaddar R; Yaseri AF
    Cell Mol Biol Lett; 2022 May; 27(1):35. PubMed ID: 35508982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability in the durability of CRISPR-Cas immunity.
    Chabas H; Nicot A; Meaden S; Westra ER; Tremblay DM; Pradier L; Lion S; Moineau S; Gandon S
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180097. PubMed ID: 30905283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
    Tan JJ; Peng YZ; Huang GT
    Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of CRISPR-Cas systems by mobile genetic elements.
    Sontheimer EJ; Davidson AR
    Curr Opin Microbiol; 2017 Jun; 37():120-127. PubMed ID: 28668720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.